Close

Jefferies Bumps Price Target on VIVUS (VVUS) Following Q4, Keeps Underperform Rating

February 29, 2012 10:05 AM EST
Get Alerts VVUS Hot Sheet
Price: $0.47 --0%

Rating Summary:
    3 Buy, 6 Hold, 4 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 16 | Down: 11 | New: 13
Join SI Premium – FREE
Jefferies bumped its price target on Vivus (NASDAQ: VVUS) from $11 to $12 following Q4 results but kept its Underperform rating.

The firm comments,"VVUS reported 4Q11 earnings and provided an update on the European filing for Qnexa, its lead product candidate for the treatment of obesity. Separately, VVUS announced a follow-on offering of up to 9.8m shares. With VVUS shares trading in the $20s, we continue to believe the current risk-reward is unfavorable going into the April FDA decision based on the risk of a potential delay."

Q1 EPS goes up from ($0.22) to ($0.21), FY12 down from $0.51 to $0.44 and FY13 down from $0.70 to $0.65.

For an analyst ratings summary and ratings history on Vivus click here. For more ratings news on Vivus click here.

Shares of Vivus closed at $21.26 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co, Earnings